Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 4 Interventional

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

ClinicalTrials.gov ID: NCT05090371

Public ClinicalTrials.gov record NCT05090371. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 12:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open Label, Multi-center, Active-comparator Study to Assess Efficacy, Safety & Tolerability of Ofatumumab 20mg sc Monthly Versus Continued Current Therapy in Relapsing-remitting Multiple Sclerosis After Elevation of Serum Neurofilament Light Levels (SOSTOS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofatumumab versus staying on their continued current therapy. This study will also look at whether an elevated serum neurofilament light (NfL) level predicts enhanced benefit from a switch to ofatumumab.

Study identification

NCT ID
NCT05090371
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
136 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2, 2022 (Actual)
Primary completion
Apr 13, 2027 (Estimated)
Completion
Apr 13, 2027 (Estimated)
Last update posted
May 29, 2026

2022 – 2027

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
37
Facility City State ZIP Site status
Alabama Neurology Associates PC Birmingham Alabama 35209 —
North Central Neurology Associates PC Cullman Alabama 35058 —
Radiant Research Chandler Chandler Arizona 85224 —
Arizona Neuroscience Research LLC Phoenix Arizona 85032 —
University of California at Los Angeles Torrance California 90509-2004 —
Neurology of Central FL Res Ctr Altamonte Springs Florida 32714 —
S And D Clinical Research Cape Coral Florida 33904 —
Homestead Assoc In Research Inc Homestead Florida 33033 —
Neurology Associates PA Maitland Florida 32751 —
Orlando Health Clinical Trials Orlando Florida 32806 —
Emerald Coast Neurology Pensacola Florida 32514 —
University Of South Florida Tampa Florida 33612 —
Kootenai Health Coeur d'Alene Idaho 83815 —
Neuro Medial Clinic of Central Louisiana Alexandria Louisiana 71301 —
International Neurorehab Institute Lutherville Maryland 21093 —
Reliant Medical Group Worcester Massachusetts 01608 —
Henry Ford Hospital Detroit Michigan 48202-2689 —
Memorial Healthcare Owosso Michigan 48867 —
University of Mississippi Medical Center Jackson Mississippi 39216-4505 —
St Barnabas Medical Center Livingston New Jersey 07039 —
Jersey Shore University Medical Ctr Neptune City New Jersey 07753 —
SUNY Upstate Medical Center Syracuse New York 13210 —
University Of NC At Chapel Hill Chapel Hill North Carolina 27599 9500 —
Piedmont HealthCare Charlotte North Carolina 28210 —
Velocity Clinical Research Raleigh North Carolina 27607 —
Palmetto Clinical Research Summerville South Carolina 29485 —
Sibyl Wray MD Neurology PC Knoxville Tennessee 37922 —
Clinical Trial Network Houston Texas 77074 —
Neuro Mind Clinical Trials Ltd Co Katy Texas 77449 —
Covenant Medical Group Lubbock Texas 79410 —
West Texas Cancer Center Odessa Texas 79761 —
Tranquil Clinical Research Webster Texas 77598 —
Sentara Neuroscience Institute Virginia Beach Virginia 23456 —
Evergreen Health Multiple Sclerosis Center Kirkland Washington 98034 —
Swedish Medical Center Seattle Washington 98122-4379 —
Aurora BayCare Medical Center Green Bay Wisconsin 54311 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05090371, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05090371 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →